SciClone Pharmaceuticals (Holdings) Ltd SCCPF
$0.83
Last Updated: Jun 07, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
SCCPF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, SciClone Pharmaceuticals (Holdings) Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
SciClone Pharmaceuticals (Holdings) Ltd. Stock Analysis SCCPF
United States Health Care Small Cap SciClone Pharmaceuticals (Holdings) Ltd. is an investment holding company which manufactures and markets immune and oncology pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 1,050 full-time employees. The firm and its subsidiaries are principally engaged in developing and commercializing a portfolio of marketed products as well as pipelines with potential in their focused therapeutic areas including oncology and severe infection. The Company’s main products comprise Zadaxin, Zometa, Oravig, Angiomax, Endoxan, Holoxan, Cytosafe, Farlutal, Campto and Vizimpro. The Company’s pipeline products include ORSERDU, Vaborem, Vibativ, RRx-001 and Omburtamab. The Company’s products are mainly used in fields such as tumors, urinary tract infections, and skin and soft tissue infections. The firm mainly conducts its businesses in the domestic market.
SciClone Pharmaceuticals (Holdings) Ltd (SCCPF) Chart
Financial Metrics & Statements of SciClone Pharmaceuticals (Holdings) Ltd (SCCPF)
FAQ's for SciClone Pharmaceuticals (Holdings) Ltd (SCCPF)
- As of August 2026, SciClone Pharmaceuticals (Holdings) Ltd SCCPF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes SciClone Pharmaceuticals (Holdings) Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in SciClone Pharmaceuticals (Holdings) Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of SciClone Pharmaceuticals (Holdings) Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of SciClone Pharmaceuticals (Holdings) Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of SciClone Pharmaceuticals (Holdings) Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for SciClone Pharmaceuticals (Holdings) Ltd (SCCPF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
